Snt Biotech Announces a Partnership with Waters Corporation to Bring the Most Comprehensive FDA-Cleared At-Home HPV Cervical Cancer Screening Tool Available in the U.S. Today to Patients PR Newswire (Press Release) 17:34
ZBiotics® and Gurney’s Montauk to Host Creator Overnight as Brand Debuts as Official Summer Pre-Alcohol Partner Business Wire (Press Release) 15:01
PTAB Reaffirms Broad Institute Priority in CRISPR-Cas9 Interference No. 106, 115: What the Decision Signals for Biotech Innovation... JD Supra 14:54
LyGenesis Receives Award from Breakthrough T1D® to Fund a Research Project to Induce Immune Tolerance to Pancreatic Islet Transplantation PR Newswire (Press Release) 13:48
Gilead’s Trodelvy approved by EC as first-line treatment for metastatic triple-negative breast cancer PMLiVE 13:36
Chonnam National University Identifies Dual-Function Rice Gene That Boosts Drought Tolerance and Grain Yield PR Newswire (Press Release) 13:36
VERAXA Biotech Expands R&D Hub In Heidelberg As Innovative BiTAC™-TCE And ADC Programs Advance Towards Clinical Development Laboratory Network 13:25
Hatch BioFund Announces Investment in Optimeos Life Sciences to Advance Novel Nanoparticle Platform for the Delivery of Therapeutic Nucleic Acids and Proteins Business Wire (Press Release) 13:18
Lakewood-Amedex Biotherapeutics Announces World-Renowned Expert David G. Armstrong, M.D., Ph.D., as Study Chair for Phase 2a Trial of Nu-3 in Infected Diabetic Foot Ulcers PR Newswire (Press Release) 13:04
MRM Health Strengthens Board with Michel Detheux as Chairman and Hans-Jürgen Wörle as Independent Director as MH002 Advances Through Phase 2b Business Wire (Press Release) 12:06
Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial Business Wire (Press Release) 12:05
Pheno Therapeutics Granted FDA IND Clearance For Lead Multiple Sclerosis Therapeutic Candidate PTD802 Drugs Discovery Online 11:52
Gandeeva And Zymeworks Use Cryo-EM To Accelerate Antibody Drug Discovery Drugs Discovery Online 11:42
BioMendics Receives FDA Fast Track Designation For BM-3103 (TolaSure Gel) For Epidermolysis Bullosa Simplex Drugs Discovery Online 11:01
Lenz Therapeutics And Arrotex Partner To Commercialize Vizz In Australia And New Zealand RTT News 10:49
World-first gene therapy to target devastating rare immune disorder NHS Blood and Transplant (Press Release) 10:44
Australia: key patentability considerations and strategies for enforcement amid 2026 changes IAM 09:38
[BIO USA 2026] ABL Bio bets on Neok Bio to create US-Style value through later-stage clinical development Korea Biomedical Review 09:01
Wave Life Sciences Starts Phase 2a Inlight Trial Of Wve-007 In Obesity And Metabolic Disease RTT News 08:37
Innovative Molecules Announces First Patient Dosed in Phase 2a Trial of Adibelivir (IM-250), Advancing Company into Late-Stage Clinical Development PR Newswire (Press Release) 07:21
Globally Recognized Impact Investors Back Leyden Labs’ Mission to Transform Protection Against Respiratory Viruses with €40 Million Investment Business Wire (Press Release) 07:02
Circulate Health announces exclusive partnership with Reborne to bring its advanced therapeutic plasma exchange protocols to UK for first time PR Newswire (Press Release) 07:01